Actively Recruiting

Phase Not Applicable
Age: 20Years - 50Years
All Genders
ID05393739

Effect of Transcranial Magnetic Stimulation on Visual Functions of Adult Amblyopia: a Preliminary Study

Led by National Taiwan University Hospital · Updated on 2025-06-22

30

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Amblyopia is a common cause of vision impairment affecting about 3% of adults. It results from disrupted normal visual stimuli and underdevelopment of the visual cortex, leading to lasting deficits in vision. Causes include refractive errors, anisometropia, strabismus, and visual deprivation. Because functional recovery is difficult after the critical period ends, there is currently no established effective treatment for adults with amblyopia. Researchers are studying the effects of repetitive transcranial magnetic stimulation (rTMS), specifically theta burst stimulation (TBS), as a potential treatment for adult amblyopia due to its ability to stimulate brain function non-invasively. Participants will receive one of three types of TBS: intermittent (iTBS), continuous (cTBS), or sham stimulation. During treatment, they will look at a visual stimulus on a computer screen and continue visual training for 20 minutes after the stimulation, which lasts about 1 to 3 minutes. In the iTBS group, the amblyopic eye views the stimulus, while in the cTBS group, the non-amblyopic eye does. The sham group receives a placebo stimulation with reduced intensity and coil orientation tilted. Each participant will have three sessions of stimulation within one week. Visual functions including best corrected visual acuity (BCVA), contrast sensitivity, and stereoacuity will be tested immediately after each TBS session, after completing the three sessions within one week, and again two weeks later to assess lasting effects. The study uses a randomized design and single masking to compare the outcomes of the different TBS regimens. The total participation period for each participant is about one month.

CONDITIONS

Brief Title

Effect of Transcranial Magnetic Stimulation on Visual Functions of Adult Amblyopia: a Preliminary Study

Who Can Participate

Age: 20Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult amblyopia participants aged 20 to 50 years old
  • At least a two-line difference in best corrected visual acuity (BCVA) between the two eyes
  • Presence of an amblyogenic factor and a history of amblyopia treatment
Not Eligible

You will not qualify if you...

  • Unstable vital signs
  • History of brain injury or head trauma
  • Neurological or psychiatric disease
  • Seizures or family history of seizures
  • Pregnancy
  • Uncontrolled migraine or presence of metallic implants or shunt in the head or torso
  • Wide region of ischemic cicatrix, multiple sclerosis
  • Taking tricyclic antidepressants, analgesics, or drugs that lower seizure threshold
  • Experienced sleep disorders during rTMS treatment
  • Severe alcoholism or taking seizure medications
  • Severe heart diseases or uncontrollable migraine caused by high intracranial pressure

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - 1 week

Participants receive theta burst transcranial magnetic stimulation (TBS) sessions, looking at a visual stimulus while the stimulation is applied. The stimulation lasts about 1 to 3 minutes per session, followed by 20 minutes of visual training. Participants receive three TBS sessions within one week.

3 visits in one week

Follow-up

Duration - 2 weeks

Participants return for visual function tests to evaluate the long-term effects of the stimulation after 2 weeks.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

National Taiwan University Hospital

Taipei County, Taiwan, 100225

Actively Recruiting

Loading map...

Research Team

T

Tzu-Hsun Tsai, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

3

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here